AVITA Medical, Inc.
RCEL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $139 | $214 | $335 |
| - Cash | $15 | $12 | $15 | $14 |
| + Debt | $5 | $45 | $44 | $46 |
| Enterprise Value | – | $172 | $243 | $367 |
| Revenue | $17 | $18 | $19 | $18 |
| % Growth | -7.4% | -0.5% | 0.6% | – |
| Gross Profit | $14 | $15 | $16 | $16 |
| % Margin | 81.3% | 81.2% | 84.7% | 87.6% |
| EBITDA | -$11 | -$8 | -$12 | -$10 |
| % Margin | -66.4% | -44% | -65.3% | -53.6% |
| Net Income | -$13 | -$10 | -$14 | -$12 |
| % Margin | -77.3% | -53.9% | -74.9% | -63% |
| EPS Diluted | -0.46 | -0.38 | -0.53 | -0.44 |
| % Growth | -21.1% | 28.3% | -20.5% | – |
| Operating Cash Flow | -$5 | -$10 | -$10 | -$8 |
| Capital Expenditures | -$1 | -$1 | -$0 | -$2 |
| Free Cash Flow | -$6 | -$11 | -$11 | -$10 |